We are focusing on strategies to deliver therapeutics via in vivo delivery of gene transfer vectors to generate ectopic “protein factories” capable of secreting therapeutic proteins into both the lung lumen and the systemic circulation.
Dr j Robinson, Prof A Morgan, Prof A Goldman, Dr M E Webb
21 January 2019
Autoantibody-mediated inflammatory diseases are characterised by a proinflammatory feedback loop which leads to the destruction of tissues, prolonged pain, fatigue and subsequent reduction in life quality.
We are now accepting applications for a Cancer Research UK funded PhD studentship to start in September 2019. Barts Cancer Institute has an international reputation for cancer research, with world renowned experts in the field.
MRC Centre for Inflammation Research
Dr P Ramachandran, Prof N Henderson, Prof T Freeman
7 January 2019
Background. Chronic liver disease is estimated to affect 844 million people worldwide, with over 2 million deaths per year. Liver fibrosis (or scarring) is a feature of advanced chronic liver disease of any aetiology and predicts adverse patient outcomes.
The World Health Organization (WHO) has declared antimicrobial drug resistance (AMR) one of the greatest threats to human health, and it is predicted that this phenomenon will kill 10 million people annually by 2050 if not addressed.